Back to Search

ALAN LYSS, MD

MD

Hematology & Oncology Physician

NPI: 1013920651Individual

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

R2C26(MO)

Research & Publications (10)

Novel doublets in extensive-stage small-cell lung cancer: a randomized phase II study of topotecan plus cisplatin or paclitaxel (CALGB 9430).
PMID 14662044·Clin Lung Cancer·2002
3-trial
Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.
PMID 19671875·Clin Cancer Res·2009
4-observational
Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer.
PMID 19075278·J Clin Oncol·2009
3-trial
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel.
PMID 18234424·Cancer Treat Rev·2008
4-observational
Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol INT-0102.
PMID 16293862·J Clin Oncol·2005
4-observational
Induction paclitaxel/carboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited-access study--CALGB 9534.
PMID 16098244·Clin Lung Cancer·2005
3-trial
Neoadjuvant and adjuvant chemotherapy with doxorubicin and docetaxel in locally advanced breast cancer.
PMID 15585077·Clin Breast Cancer·2004
3-trial
70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808.
PMID 15145163·Int J Radiat Oncol Biol Phys·2004
3-trial
Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B.
PMID 12733147·Cancer·2003
3-trial
Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain.
PMID 11516599·J Pain Symptom Manage·2001
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
3015 N BALLAS RD
SAINT LOUIS, MO 63131

Quick Facts

NPI
1013920651
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
10

Are you this provider?

Claim Your Profile